Page 69 - MEMORIA ANUAL 2019 SEHH-FEHH

Programa EsPañol dE TraTamiEnTos En HEmaTología (PETHEma)
MEMORIA ANUAL 2019
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
JM, Torres-Juan M, Moraleda JM, Martínez C, Vázquez A, Gutiérrez G, Caballero D, San Miguel JF, Mateos MV, Pérez-Simón JA. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma. Biol Blood Marrow Transplant. 2019 Sep;25(9):1703-12. doi: 10.1016/j. bbmt.2019.04.026.
• Mazzarella L, Botteri E, Matthews A, Gatti E, Di Salvatore D, Bagnardi V, Breccia M, Montesinos P, Bernal T, Gil C, Ley TJ, Sanz M, Bhaskaran K, Coco FL, Pelicci PG. Obesity is a risk factor for acute promyelocytic leukemia: evidence from popula- tion and cross-sectional studies and correlation with FLT3 mutations and poly- unsaturated fatty acid metabolism. Haematologica. 2020 Jun;105(6):1559-66. doi: 10.3324/haematol.2019.223925.
• Salamero O, Martínez-Cuadrón D, Sobas M, Benavente C, Vives S, De la Serna J, Pérez-Encinas M, Escoda L, Gil C, Brunet S, Ramos F, Esteve J, Amigo M, Krsnik I, Manso F, Arias J, González-Campos J, Serrano J, Oleksiuk J, Barrios M, García- Boyero R, Novo A, Sanz MA, Montesinos P; PETHEMA and PALG Groups. Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry. Leuk Lymphoma. 2019 Nov;60(11):2720-32. doi: 10.1080/10428194.2019.1607327.
• Genescà E, Morgades M, Montesinos P, Barba P, Gil C, Guàrdia R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, González-Gil C, Zamora L, Ramírez JL, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Juncà J, Ciudad J, Orfao A, Ribera JM. Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia. Haematologica. 2020 Jun;105(6):e294-e297. doi: 10.3324/haematol.2019.225078.
• Sobas M, Czyž A, Montesinos P, Armatys A, Helbig G, Hołowiecka A, Pluta A, Zar- zycka E, Piatkowska-Jakubas B, Majcherek M, Lewandowski K, Gołos A, Paluszewska M, Podhorecka M, Oleksiuk J, Skret A, Hawrylecka D, Guzicka-Kazimierczak RE, Wa- tek M, Gromek T, Charlinski G, Grosicki S, Holojda J, Minkiewicz W, Martínez-Cuadrón D, Sanz MA, Wróbel T, Wierzbowska A, Giebel S. Outcome of a Real-Life Popula- tion of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):105-13. doi: 10.1016/j.clml.2019.09.616.
69